Literature DB >> 7092002

Antibiotic therapy of acute exacerbations of chronic bronchitis. A controlled study using tetracycline.

M B Nicotra, M Rivera, R J Awe.   

Abstract

We conducted a double-blind, randomized, placebo-controlled trial in 40 patients to evaluate the need for antibiotics in acute exacerbations of chronic bronchitis. All patients were sufficiently ill to require hospitalization although none needed ventilatory support; the presence of pneumonia was excluded. Treatment consisted of bronchodilators, corticosteroids, and either tetracycline, 500 mg, or placebo by mouth every 6 hours for 1 week. Arterial blood gases, spirometric tests, bacteriologic evaluation of sputum, and patient and physician evaluation of the severity of illness were assessed at the beginning and end of the study. All patients improved both symptomatically and by objective measures of lung function. At the end of the study period there were no differences between those patients receiving tetracycline and those receiving placebo. We conclude that antibiotic therapy is not needed in moderately ill patients with exacerbations of chronic bronchitis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092002     DOI: 10.7326/0003-4819-97-1-18

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  34 in total

1.  [Antimicrobial treatment of patients with severe acute exacerbation of COPD].

Authors:  B Klapdor; S Ewig
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-22       Impact factor: 0.840

2.  The use of antimicrobial drugs in office practice.

Authors:  M R Achong
Journal:  Can Fam Physician       Date:  1982-12       Impact factor: 3.275

3.  Nonvalue of sputum culture in the management of lower respiratory tract infections.

Authors:  J R Lentino; D A Lucks
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

4.  Compulsive antibiotic training.

Authors:  T Dixon
Journal:  Can Fam Physician       Date:  1988-10       Impact factor: 3.275

5.  Standards for the use of ordinal scales in clinical trials.

Authors:  C R MacKenzie; M E Charlson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

Review 6.  Antimicrobial therapy for lower respiratory tract infections.

Authors:  P J van den Broek
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

7.  Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.

Authors:  A Verghese; D Roberson; J H Kalbfleisch; F Sarubbi
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  [Smoking and lower respiratory tract infection].

Authors:  R B Brown
Journal:  Infection       Date:  1987       Impact factor: 3.553

9.  Antimicrobials in acute exacerbations of chronic obstructive pulmonary disease - An analysis of the time to next exacerbation before and after the implementation of standing orders.

Authors:  Rob D Goddard; Shelly A McNeil; Kathryn L Slayter; R Andrew McIvor
Journal:  Can J Infect Dis       Date:  2003-09

10.  Double-blind comparative study of ofloxacin (Hoe 280) and trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbations of chronic bronchitis and chronic obstructive lung disease.

Authors:  N P Boye; P Gaustad
Journal:  Infection       Date:  1991       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.